Several reports showed that the haplotypeGGCC_46/1 seems to be associated with a high mutant allele burden in JAK2 V617F positive MPN patients, being significantly enriched in patients with higher V617F allele burden [12,18,19,20,21]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.